Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Conditions
Interventions
Standard of Care
FLOSEAL Hemostatic Matrix + Standard of care
Locations
12
United States
Cedars-Sinai Orthopedic Center
Los Angeles, California, United States
Stanford Orthopedics
Redwood City, California, United States
Colorado Orthopedic Consultants, PC
Englewood, Colorado, United States
George Washington University Medical Faculty Associates
Washington D.C., District of Columbia, United States
Florida Research Associates, LLC
DeLand, Florida, United States
Shrock Orthopedic Research, LLC
Fort Lauderdale, Florida, United States
Start Date
September 1, 2011
Primary Completion Date
January 1, 2013
Completion Date
January 1, 2013
Last Updated
June 6, 2014
NCT06755697
NCT07551245
NCT06702046
NCT07548385
NCT05986292
NCT06381791
Lead Sponsor
Baxter Healthcare Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions